Creative Bioarray has many years of experience in culturing hybridoma cells for the production of specific antibodies. With advanced hybridoma platform and screening technique, as well as accumulated experience in cell culture and antibody engineering, we are dedicated to providing high quality and stable hybridomas cell lines to meet your specific requirements of research or manufacturing.
Hybridoma technology is a method used to produce large amount of monoclonal antibodies, which can be widely used in biological and medical research, disease prevention, diagnostic and treatment, and clinical applications. Monoclonal antibodies produced by hybridoma technology always retain their native structure. Once stablized, hybridomas can offer unlimited quantities of consistent, homogenized antibodies in a cost-effective manner. This is perfect for further research and application.
Hybridoma technology is mainly based on three key technologies and steps.
Figure 1. Illustration showing the production route of hybridoma technology. (Saeed, A. F., et al., 2017)
Creative Bioarray can produce the most comprehensive list of ready-to-use hybridoma cells. These cells can be used to produce various antibodies covering a wide range of antigens. Comprehensive quality control and authentication procedures are carried out on all cell lines. Cell lines can be supplied either as frozen or growing cultures.
If you are interested in our services or have any specific needs, please feel free to contact us. We look forward to cooperating with you.
Reference:
As a pioneer of biotechnology, Creative Bioarray has developed into one of the largest independent biotechnology companies in the world. We are committed to providing our customers with innovative high-quality products and services through discovering, developing, and manufacturing.